<< USANA Health Sciences announces $40 million for share repurchase program | Study to determine how often chronic Lyme disease is diagnosed and treated >>

Read in | English | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Русский | Polski

USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA

Published on September 2, 2010 at 12:56 AM · No Comments

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.

These generic atomoxetine hydrochloride capsules are equivalent to Eli Lilly's Strattera ® capsules and include six strengths: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, and 100 mg.

Annual sale in US for these strengths of branded and generic atomoxetine hydrochloride capsules is estimated at over $ 530 million.

Atomoxetine Hydrochloride capsules are indicated for the management of attention deficit hyperactivity disorder in children aged 6 and older,teens and adults.

Source Sun Pharma

9780b455-184b-4e50-8d2d-38e1cbcacb47|1|3.0

Posted in: Child Health News | Medical Condition News | Pharmaceutical News

Tags: Cardiology, Gastroenterology, Neurology, New Drug Application, Ophthalmology, Psychiatry

Related posts

Long-duration space voyages can affect astronauts' visual systemsA new study sponsored by NASA finds that space flights lasting six months or more can cause a spectr...
Noncombatant military personnel at greater risk of developing PTSDNoncombatant military personnel do not engage in direct combat with the enemy during war, but they s...
Momenta Pharmaceuticals provides update on generic Lovenox litigationMomenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engi...
USFDA approves Sun Pharma's generic Venlafaxine Hydrochloride Extended Release tablets ANDASun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (AND...
Important advance in our understanding of colorectal cancerAn international team of medical scientists has made an important advance in our understanding of th...
Estimates may overstate toll of sudden cardiac deathResearchers trying to get a precise picture of sudden cardiac death in Portland, Ore. found that che...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.